Plasma Homocysteine Levels Increased Risk of Levodopa-Induced Dyskinesia in Parkinson's Disease

被引：0
|
作者：
Lin, J. J.
Yueh, K. Y.
机构：
来源：
MOVEMENT DISORDERS | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S674 / S674
页数：1
相关论文
共 50 条
  • [21] Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease
    Delamarre, Anna
    Tison, Francois
    Li, Qi
    Galitzky, Monique
    Rascol, Olivier
    Bezard, Erwan
    Meissner, Wassilios G.
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (06) : 789 - 793
  • [22] Propofol Withdrawal Dyskinesia in a Parkinson's Disease Patient with Levodopa-Induced Dyskinesia
    Nakajima, Asuka
    Iwamuro, Hirokazu
    Tokugawa, Joji
    Odo, Masahiko
    Shimo, Yasushi
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2023, 50 (02) : 322 - 323
  • [23] Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s disease
    Anna Delamarre
    François Tison
    Qin Li
    Monique Galitzky
    Olivier Rascol
    Erwan Bezard
    Wassilios G. Meissner
    Journal of Neural Transmission, 2019, 126 : 789 - 793
  • [24] Coffee Consumption and Risk of Levodopa-Induced Dyskinesia in Parkinson's Disease: The FRAGAMP Study
    Nicoletti, Alessandra
    Zappia, Mario
    MOVEMENT DISORDERS, 2015, 30 (13) : 1854 - 1856
  • [25] High levodopa plasma concentration in the acute levodopa challenge test predicts levodopa-induced dyskinesia in Parkinson's disease
    Shiraishi, T.
    Nishikawa, N.
    Mukai, Y.
    Takahashi, Y.
    MOVEMENT DISORDERS, 2020, 35 : S479 - S480
  • [26] The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia
    Zhang, Yu-han
    Tang, Bei-sha
    Song, Chen-yuan
    Xu, Qian
    Lou, Ming-xin
    Liu, Zhen-hua
    Yu, Ren-he
    Yan, Xin-xiang
    Guo, Ji-feng
    NEUROSCIENCE LETTERS, 2013, 556 : 109 - 112
  • [27] Clinical signs associated with levodopa-induced dyskinesia in Parkinson's disease
    Kipfer, S.
    Stephan, M. A.
    Schuepbach, M.
    Kaelin-Lang, A.
    MOVEMENT DISORDERS, 2009, 24 : S267 - S267
  • [28] A Web Resource for Levodopa-Induced Dyskinesia Genetics in Parkinson's Disease
    Blankenburg, Hagen
    Falla, Marika
    Schwienbacher, Christine
    Fabbrini, Giovanni
    Berardelli, Alfredo
    Pramstaller, Peter P.
    Domingues, Francisco S.
    NEUROINFORMATICS, 2017, 15 (03) : 297 - 300
  • [29] Effect of Safinamide on Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease
    Bhatt, Mohit
    Chirileanu, Dana
    Meshram, Chandrashekhar
    Stanzione, Paolo
    Forrest, Emma C.
    NEUROLOGY, 2010, 74 (09) : A319 - A319
  • [30] Levodopa-induced Dyskinesia in Parkinson’s disease: Epidemiology, etiology, and treatment
    Theresa A. Zesiewicz
    Kelly L. Sullivan
    Robert A. Hauser
    Current Neurology and Neuroscience Reports, 2007, 7 : 302 - 310
12345